Bevacizumab regulates inflammatory cytokines and inhibits VEGFR2 signaling pathway in an ovalbumin-induced rat model of airway hypersensitivity
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Link
https://link.springer.com/content/pdf/10.1007/s10787-021-00798-8.pdf
Reference57 articles.
1. Aceves SS, Broide DH (2008) Airway fibrosis and angiogenesis due to eosinophil trafficking in chronic asthma. Curr Mol Med 8:350–358
2. Adamcic U, Skowronski K, Peters C, Morrison J, Coomber BL (2012) The effect of bevacizumab on human malignant melanoma cells with functional VEGF/VEGFR2 autocrine and intracrine signaling loops. Neoplasia 14:612-IN16
3. Agudo J et al (2014) The miR-126–VEGFR2 axis controls the innate response to pathogen-associated nucleic acids. Nat Immunol 15:54–62
4. Alfaro C et al (2009) Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes. Br J Cancer 100:1111–1119
5. Barratt S, Medford AR, Millar AB (2014) Vascular endothelial growth factor in acute lung injury and acute respiratory distress syndrome. Respiration 87:329–342. https://doi.org/10.1159/000356034
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids;Biomedicines;2023-12-30
2. Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer;Pharmaceuticals;2023-09-29
3. Tyrosol improves ovalbumin (OVA)-induced asthma in rat model through prevention of airway inflammation;Naunyn-Schmiedeberg's Archives of Pharmacology;2021-07-21
4. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma;BMC Cancer;2021-06-11
5. Immune-related adverse event profile of combination treatment of PD-(L)1 checkpoint inhibitors and bevacizumab in non-small cell lung cancer patients: data from the FDA adverse event reporting system;Translational Lung Cancer Research;2021-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3